Mice Model Market Size By Mice Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production and Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Dec 2019  |  Report ID: GMI4473  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 450   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Mice Model Market size surpassed USD 6.9 billion in 2018 and is projected to achieve over 7.7% CAGR up to 2025. 
 

Mice Model Market

Get more details on this report - Request Free Sample PDF
 

The use of mice as model organisms is the ability to model human disease in mice for research in biomedical science and psychology. One of the essential factors for using the model in research is its 95% genetic similarity with the humans. Hence, by studying mice model that have indications of diseases such as diabetes, cancer, and Alzheimer’s, the researchers can learn more about how these diseases might be treated in patients. Thus, growing use of mice for research purpose has been instrumental in achieving the goal and is expected to play an important role in augmenting the market size.
 

The concept of lab mice was introduced in 1920’s by Clarence Cook Little who believed that mice was the perfect model for studying cancer. Since cancer is an inheritable disease, Clarence Cook Little thought that mice were an ideal subject for his experiments due to their short life span and low maintenance. However, rats were the first mammalian species to be developed for use in the laboratory. Most in vivo assays were initially established and improved in the rat. Though, over the past thirty years, mice have rapidly overtaken rats as the preferred animal research model leading to increased mice model market growth.
 

The shift in popularity from rat to mice among scientists is chiefly owing to the initiation of the first transgenic mice in 1987 and development of targeted gene manipulation. Transgenic mice closely model the physiology and function of human diseases that further enable scientists to examine the effect of individual genes on disease. Also, from testing dietary supplements to formulating new cancer drugs, mice play a critical role in developing medical wonders. Mice are further used in sensory, aging, behavioural, nutrition and genetic studies along with testing anti-craving medication that could potentially end drug addiction. However, growing concern for the wellbeing of animals and rising awareness pertaining to animal rights will hinder the mice model industry growth.
 

Mice Model Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: USD 6.9 Billion
Historical Data for: 2014 to 2017 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 7.7% 2025 Value Projection: USD 11.7 Billion
Pages: 450 Tables, Charts & Figures: 387
Geographies covered (30): U.S., Canada, Germany, UK, France, Spain, Italy, Switzerland, Netherlands, Czech Republic, Poland, Belgium, Finland, Hungary, Denmark, Ireland, Sweden, China, Japan, Australia, South Korea, New Zealand, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Israel
Segments covered: Mice type, Technology, Applications, Use, End-use
Companies covered (8): Envigo, genOway, Charles River, Transviragen Inc., Janvier Labs, Taconic Biosciences Inc., Transpogen Biopharmaceutical, Inc. and The Jackson Laboratory.
Growth Drivers:
  • Rise in the advancements of gene editing tools
  • Rising demand for humanized mice models
  • Physiological similarities between human and mice
  • Growing consumption of personalized medicine in developing and developed countries
Pitfalls & Challenges:
  • Ongoing developments of alternative methods to animal testing
  • Strict regulations and guidelines
  • Growing opposition on mice testing by several organizations

Request 15% Free Customization on this Report
 

Rising demand for mice model for cancer research will boost the adoption across the globe

Growing demand for mice model in cancer research for understanding the genetic basis of tumour development and cancer progression is boosting the market growth. Mice model are also used to check the efficacies of different anti-cancerous agents. Some of the most influential cancer drugs in the field trace their origins to discoveries with mice. For instance, Herceptin, a popular drug for breast cancer patients was developed in mice that enhances the long-term survival of the patient. Mice model have brightened the future of cancerous treatment and cure. Studies with mice have highlighted a variety of exciting potential therapies of cancer, including a vaccine to prevent breast cancer, tiny nanoparticles that delivers toxins to ovarian cancer cells and phototherapy that delivers light to destroy deep tumours. Other factors that have fostered the adoption of mice model are its easy handling and low maintenance. Hence, the above-mentioned factors are responsible for boosting the mice model market demand.  
 

Increasing usage of knockout mice model to study various complex disorders will boost the market outlook

Based on mice type, the market is segmented as inbred, outbred, knockout, hybrid and others. Knockout mice model market is expected to witness a lucrative growth at 9.5% in the upcoming years. The high growth rate is owing to increase in usage of knockout mice model in studying and modelling different kinds of cancer, diabetes, lifestyle disorders, neurological disorders and heart diseases. The other factor that is contributing in the adoption of knockout mice model is the information that these models offer to the researchers regarding similar gene that causes or contributes to specific diseases in humans. These models are also further extensively used in the study of several malaria-induced pathologies. Hence, all the above-mentioned factors are contributing in the segmental growth and thereby propelling the mice model industry demand.
 

 CRISPR, a gene editing technology is expected to boost the mice model industry growth

U.S. Mice Model Market By Technology

Get more details on this report - Request Free Sample PDF
 

Based on technology, the market is segmented into CRISPR, embryonic stem cell injection, nuclear transfer, microinjection and others. CRISPR technology held significant market share in the year 2018 and is forecasted to expand at 8.1% CAGR over the forecast period. The high growth rate is owing to several factors such as generating custom knockouts & point mutations at significant cost reduction and reduces timelines compared to traditional gene targeting methods. CRISPR technology is further expected to pave the way for large number of new genetic mice model that is mainly used for oncology & neuroscience research. Thus, owing to these benefits CRISPR technology is expected to gain a significant traction thereby, enhancing the market growth in the upcoming years.
 

Growing application of mice model in research and development will augment the demand and adoption, thereby propelling the market growth

Based on application, the market is segmented into research and development, production and quality control, academics and others. Research and development segment held significant market share and accounted for around USD 4.9 billion in 2018. Rising demand for mice model in research and development activity is significantly growing with each passing year. Mice model are considered as the best models for understanding the pathogenic mechanism of Alzheimer’s disease and offers therapeutic approaches to tackle clinical progression of the disease. Thus, all these factors will positively contribute to segmental growth in the upcoming years.
 

Application of mice model in human diseases lead to effective results that will further enhance the market trends

Based on use, the market is segmented as human and veterinary. The use of animal testing for human research held substantial market share in 2018 and is projected to expand at around 7.7% CAGR from 2019 to 2025. The adoption of mice model for understanding of several diseases such as cancer, cardiovascular diseases, diabetes, and neurological diseases is fostering the segmental growth. Furthermore, genetic similarity between humans and mice is one of the factors that is contributing to the market growth positively.
 

Ongoing research and development activities in pharma industry will enhance the market growth

Based on end-use, the industry is segmented as companies, organizations, academic & research institutes and contract research organizations. The companies segment held the largest revenue in the year 2018 and was valued at around USD 4.3 billion. The high revenue is due to increase in research and development activities in biotechnology and pharmaceutical industry. The demand for mice as a preclinical animal model is owing to several advantages that the mice model possesses over other animal models. With a short gestation period of twenty days, inheritance studies are accomplished in a shorter time frame than other species with longer gestation period. Hence, all these factors are contributing in propelling the companies segment market growth positively and is projected to witness a substantial growth over the forecast period.
 

Presence of key players and rapidly increasing animal testing in biomedical research in the U.S. will boost the global market size

Europe Mice Model Market By Country

Get more details on this report - Request Free Sample PDF
 

U.S. dominated the North America mice model market outlook with revenue of around USD 5.7 billion in the year 2018. Presence of major pharmaceutical and biotechnology companies, along with established research and development institutes will enhance the industry growth in the country. For instance, in the U.S. each year around 90 million mice are used for research purposes. The ongoing research on cancer and neurological disorders is propelling the market growth in the country. For instance, in 2019, according to the Alzheimer’s Association, Alzheimer’s is the sixth leading cause of death in the U.S. and around 5.8 million Americans living with Alzheimer’s. Furthermore, after every 65 second an individual in the country develops is diagnosed with the disease. Pharma companies are consistently developing new drugs in order to cure these diseases; therefore, mice are a preferred choice of researchers for understanding these diseases. Hence, the aforementioned factors are will play vital role in propelling the market growth.
 

UK market held the largest revenue share in 2018 and was valued at around USD 145 million. The high revenue share is attributed to the growing adoption of mice for research and development in the pharmaceutical companies. In the year 2018, around 2.7 million mice were used for the research purpose across the UK. These models are used to study atherosclerosis and understanding the abnormalities in embryo development. Thus, rise in number of these models for testing is expected to augment the market share in the upcoming years.  
 

 Execution of strategies such as partnerships and collaborations by major industry players will boost the market demand

Some of the leading players in the industry include Charles River, Envigo, genOway, Transviragen Inc., Janvier Labs, Taconic Biosciences Inc. and Transpogen Biopharmaceutical, Inc. These players have been engaging into partnerships and collaborations, acquisitions & mergers to increase the product portfolio and reinforce their market position.
 

Recent industry developments:

  • In July 2019, Taconic Biosciences announced the launch of the 1st commercially produced NASH diet-induced (nonalcoholic steatohepatitis) mice model. Increasing prevalence of NAFLD has boosted the demand and in turn created the market for a NASH animal model. This launch will aid the company in increasing its market sales and strengthening its global presence.
     
  • In December 2018, the Jackson Laboratories had led the research and worked to develop a new mouse population that would model both human Alzheimer’s and human genetic diversity at same time.
     

The mice model market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2014 to 2025, for the following segments:

By Mice Type

  • Inbred
  • Outbred
  • Knockout
  • Hybrid
  • Others

By Technology

  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Others

By Application

  • Research and Development
    • Infectious Disease
    • Immunological Diseases
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Genetic Diseases
    • Neurological Diseases
    • Others
  • Production and Quality Control
  • Academics
  • Others

By Use

  • Human
  • Veterinary

By End-use

  • Companies
    • Pharmaceutical
    • Biotechnology
    • Cosmetics
    • Others
  • Organisations
    • Government
    • Non-government
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Switzerland
    • Netherlands
    • Czech Republic
    • Poland
    • Belgium
    • Finland
    • Hungary
    • Denmark
    • Ireland
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • New Zealand
    • Taiwan
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
       

Frequently Asked Questions (FAQ) :

The use of mice as model organisms is the ability to model human disease in mice for research in biomedical science and psychology. One of the essential factors for using the model in research is its 95% genetic similarity with the humans.
The United States was leading the global industry with USD 5.7 billion revenue share in 2018.
Companies like Charles River, Envigo, genOway, Transviragen Inc., Janvier Labs, Taconic Biosciences Inc. and Transpogen Biopharmaceutical, Inc. are dominating the global market in the next few years.

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust


  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

GMIPulse Subscription

An interactive business analytics platform; designed to assist clients in accessing and analyzing market data on real-time basis.

Start Your Free Trial
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X